![](/img/cover-not-exists.png)
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Nonâsmall-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design
Passiglia, Francesco, Bironzo, Paolo, Righi, Luisella, Listì, Angela, Arizio, Francesca, Novello, Silvia, Volante, Marco, Scagliotti, Giorgio VittorioJournal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.07.014
Date:
August, 2020
File:
PDF, 305 KB
2020